Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2 Teratoma 1 Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Lung Neoplasms 1 Infratentorial Neoplasms 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 6 Phantoms, Imaging 6 Cyclophosphamide 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Topotecan 4 Etoposide 4 Biopsy 4 palbociclib 3 Vincristine 3 Methotrexate 3 Cisplatin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vemurafenib 2 Temozolomide 2 Radiotherapy 2 Nivolumab 2 LY3023414 2 Carboplatin 2 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rhabdoid Tumor × Craniospinal Irradiation × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡